Relive the excitement of the Patriots’ path to their fourth Super Bowl Championship with “Pumped”, a special commemorative book from The Boston Globe. Order now.

Market Mover

Pfizer lowers forecast amid sales decline

Rival generics have cut into sales of two-thirds of Pfizer’s drugs. Lipitor sales, for example, are down 55 percent to $626 million.

Associated Press/File 2012

Rival generics have cut into sales of two-thirds of Pfizer’s drugs. Lipitor sales, for example, are down 55 percent to $626 million.

Continue reading below

Pfizer Inc.’s quarterly net income rose 53 percent $2.75 billion, despite falling sales, mainly because the second-largest drug maker took big charges a year ago. The results fell short of expectations, and Pfizer cut its forecasts, blaming currency exchange rates. Overall, revenue was $13.5 billion, down 9 percent from a year earlier. The yearly profit forecast excluding one-time items was cut 6 cents to $2.14 to $2.24 per share.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking. Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com